Down-regulation of kallikrein-related peptidase 5 (<it>KLK5</it>) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions

Down-regulation of kallikrein-related peptidase 5 (<it>KLK5</it>) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions

<p>Abstract</p> <p>Background</p> <p>Kallikrein-related peptidase 5 (KLK5) is a secreted trypsin-like protease of the KLK family, encoded by the <it>KLK5 </it>gene. KLK5 has been found to cleave various extracellular matrix components, as well as to activate...

Full description

Bibliographic Details
Main Authors:	Avgeris Margaritis, Papachristopoulou Georgia, Polychronis Athanasios, Scorilas Andreas
Format:	Article
Language:	English
Published:	BMC 2011-05-01
Series:	Clinical Proteomics
Subjects:	KLK5 Breast Cancer Cancer Biomarkers Tumor Markers KLKs Kallikreins Serine Proteases Proteolysis
Online Access:	http://www.clinicalproteomicsjournal.com/content/8/1/5

Similar Items

Novel specific activity-based probes validate KLK proteases as druggable targets
by: Georgia Sotiropoulou, et al.
Published: (2022-12-01)

Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker
by: Ai Sato, et al.
Published: (2023-05-01)

Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
by: Weiwei Gong, et al.
Published: (2020-10-01)

Involvement of Kallikrein-Related Peptidases in Nervous System Disorders
by: Cinthia Mella, et al.
Published: (2020-06-01)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
by: Oliver Goldhardt, et al.
Published: (2019-08-01)

Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases
by: Marcelo B. Zani, et al.
Published: (2022-03-01)

KLK4T2 Is a Hormonally Regulated Transcript from the <i>KLK4</i> Locus
by: Åke Lundwall, et al.
Published: (2021-12-01)

Prospective quantitative gene expression analysis of kallikrein-related peptidase KLK10 as a diagnostic biomarker for childhood acute lymphoblastic leukemia
by: Shwan Majid Ahmad, et al.
Published: (2022-05-01)

Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers
by: Amiram Sananes, et al.
Published: (2023-11-01)

Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome
by: Kristi Y. Lee, et al.
Published: (2022-12-01)

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
by: Weiwei Gong, et al.
Published: (2020-02-01)

A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression
by: Yueyang Liu, et al.
Published: (2022-09-01)

Activity-Based Probes for Proteases Pave the Way to Theranostic Applications
by: Georgia Sotiropoulou, et al.
Published: (2022-04-01)

Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6
by: Sotiropoulou Georgia, et al.
Published: (2012-12-01)

Heparin Blocks the Inhibition of Tissue Kallikrein 1 by Kallistatin through Electrostatic Repulsion
by: Lina Ma, et al.
Published: (2020-05-01)

Bioinformatics analysis of human kallikrein 5 (KLK5) expression in metaplastic triple‐negative breast cancer
by: Yue Song, et al.
Published: (2023-10-01)

Interference of kallikrein 1b26 (klk1b26) translation by microRNA specifically expressed in female mouse submandibular glands: an additional mechanism for sexual dimorphism of klk1b26 protein in the glands
by: Kurihara Kinji, et al.
Published: (2011-11-01)

KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?
by: Hannu Koistinen, et al.
Published: (2021-12-01)

Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis
by: Hayet Bouzid, et al.
Published: (2022-07-01)

KLK4 Induces Anti-Tumor Effects in Human Xenograft Mouse Models of Orthotopic and Metastatic Prostate Cancer
by: Brian W.-C. Tse, et al.
Published: (2020-11-01)

The molecular function of kallikrein‐related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer
by: Thomas Kryza, et al.
Published: (2020-01-01)

Expression of kallikrein-related peptidase 7 is decreased in prostate cancer
by: Chong-Yu Zhang, et al.
Published: (2015-02-01)

Modulation of the Plasma Kallikrein-Kinin System Proteins Performed by Heparan Sulfate Proteoglycans
by: Guacyara Motta, et al.
Published: (2017-07-01)

Analysis of expression and prognosis of KLK7 in ovarian cancer
by: Chen Erhua, et al.
Published: (2020-09-01)

Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer
by: Qiliang Peng, et al.
Published: (2020-06-01)

Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond
by: Guacyara Motta, et al.
Published: (2023-08-01)

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D
by: Sawan Kumar Jha, et al.
Published: (2019-05-01)

KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study
by: Mustafa A. El Sherbini, et al.
Published: (2018-04-01)

Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
by: Kiwami Kidana, et al.
Published: (2018-03-01)

Isolation and partial characterization of a protease with kallikrein-like activity from the egg-nests of hylesia metabus (crammer 1775) (Lepidoptera: Saturnidae), preliminary communication
by: Ulf Lundberg, et al.
Published: (2010-06-01)

Evaluation of proteolytic activity and serine proteases distribution in plasma from patients with bladder cancer
by: Tatyana Synelnyk, et al.
Published: (2023-11-01)

Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma
by: Juliana B. Candido, et al.
Published: (2021-08-01)

Cut-off value for KLK3 gene expression from urine sediment to rationalize diagnosis of prostate cancer
by: Jasmin Ramić, et al.
Published: (2020-01-01)

A <it>Kallikrein 15 </it>(<it>KLK15</it>) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival
by: Song Honglin, et al.
Published: (2011-04-01)

Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2
by: Lucía Paniagua-Herranz, et al.
Published: (2024-02-01)

Expression of KLK2 gene in prostate cancer
by: Sajad Shafai, et al.
Published: (2018-01-01)

EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer
by: Kai-Jie Yu, et al.
Published: (2022-06-01)

Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line
by: Jun Lu, et al.
Published: (2019-09-01)

Kallikrein 5 Inhibition by the Lympho-Epithelial Kazal-Type Related Inhibitor Hinders Matriptase-Dependent Carcinogenesis
by: Elaine Zayas Marcelino da Silva, et al.
Published: (2021-08-01)

Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancer
by: Juliana Meola, et al.
Published: (2006-01-01)